Amphastar Pharmaceuticals (AMPH) PT Raised to $23 at Jefferies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amphastar Pharmaceuticals (AMPH) PT Raised to $23 at Jefferies

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2017

November 8, 2017 4:07 PM EST

RANCHO CUCAMONGA, Calif., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (Amphastar or the Company) today reported results for the three months ended September 30, 2017.

Third Quarter Highlights

Net revenues of $57.9 million for the third quarterGAAP net income of $0.2 million, or $0.00 per diluted share, for the third quarterAdjusted non-GAAP net income of $3.5 million, or $0.07 per diluted share, for the third quarter

Dr. Jack Zhang, Amphastars CEO, commented: The third quarter was a successful one for Amphastar with approvals of both sodium bicarbonate and neostigmine. Approvals like these will... More